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Antioxidants at Newborns
Melinda Matyas and Gabriela Zaharie
Abstract
Humans possess defense mechanisms against free radicals: enzymatic and non-
enzymatic antioxidants. Antioxidant defense is deficient in newborns and can be 
enhanced by the action of reactive oxygen species, generated by perinatal diseases 
such as respiratory distress or asphyxia. Prematurity itself will be associated with 
deficient antioxidant mechanisms, which are primarily enzymatic, but also non-
enzymatic. Under oxidative stress conditions, antioxidant defense is overcome and 
thus, low-molecular weight free iron is released, which is not bound to transferrin 
and will play a role in Fenton’s reaction, catalyzing lipid peroxidation. The gener-
ated ROS will in turn influence antioxidant defense mechanisms, stimulating their 
synthesis, as an adaptation mechanism of the body in response to the presence of 
increased ROS levels.
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1. Aim
The aim of the current chapter is to review the antioxidant status particularities 
newborn, to present the antioxidant evaluation and current opinions on antioxidant 
treatment in newborns.
2. Introduction
The human body possesses defense mechanisms against free radicals, consisting 
of enzymatic and non-enzymatic antioxidants. Antioxidant defense is deficient 
in newborns and can be enhanced by the action of reactive oxygen species, gener-
ated by perinatal diseases such as neonatal respiratory distress or birth asphyxia. 
Prematurity itself will be associated with deficient antioxidant mechanisms, which 
are primarily enzymatic, but also non-enzymatic. Antioxidant defenses, especially 
enzymatic ones, develop during the last trimester of pregnancy. Consequently, 
premature newborns will not have sufficient antioxidant defense. Under oxida-
tive stress conditions, antioxidant defense is overcome and thus, low-molecular 
weight free iron is released, which is not bound to transferrin and will play a role 
in Fenton’s reaction, catalyzing lipid peroxidation [1, 9]. Reactive oxygen species 
(ROS) production occurs through various mechanisms, of which the most com-
mon are hyperoxia, reperfusion, and inflammation. The generated ROS will in 
turn influence antioxidant defense mechanisms, stimulating their synthesis, as an 
adaptation mechanism in response to the presence of increased ROS levels. In neo-
natology, a “free radical disease” is described, which includes a number of disorders: 
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bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, 
and periventricular leukomalacia [1, 8, 17].
In the case of perinatal asphyxia, ROS will exert a considerable harmful effect on 
the brain because antioxidant levels are low and there is an increased oxygen con-
sumption during transition from fetal life to neonatal life [14, 15, 25]. Randomized 
studies on relatively large numbers of term newborns with asphyxia have demon-
strated the importance of resuscitation with atmospheric air in limiting injury and 
improving the survival rate [13, 26].
3. Antioxidants classification
Antioxidants are most commonly classified into enzymatic and non-enzymatic 
systems. Depending on their solubility, non-enzymatic antioxidants are divided 
into water-soluble and lipid-soluble antioxidants.
The main enzymatic antioxidant systems are:
• superoxide dismutase (SOD)—an enzyme that detoxifies the superoxide anion;
• catalase (CAT)—detoxifies oxygenated water and has a protective antitumor 
role;
• peroxidases—myeloperoxidase (MPO), lipid peroxidase, glutathione peroxi-
dase (GSH-Px)—mainly protect the liver;
• glutathione peroxidase (GPx) intracellular selen-protein that reduces hydrogen 
peroxide to glutathione disulfide and water;
• the system of cytochrome oxidases, which reduce oxygen; they play a role in 
reducing the amount of oxidant or potentially oxidant substances; they can be 
released into the blood and extracellular fluid.
The main non-enzymatic antioxidant systems are represented by:
• the reduced-oxidized glutathione redox cycle;
• vitamin E—which intercepts the peroxyl radical;
• vitamin C;
• carotenoids—alpha-carotene, a precursor of vitamin A, is 10 times more effec-
tive than beta-carotene;
• selenium;
• uric acid and urates;
• bilirubin;
• cysteine-rich metallothioneins;
• metal-binding proteins: albumin, transferrin, ferritin, lactoferrin, and 
ceruloplasmin;
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• amino acids such as histidine, taurine, cysteine which ensures protection 
against toxic aldehydes present in cigarette smoke, methionine which protects 
the colon;
• Heme proteins and heme-binding proteins—hemopexin, haptoglobin, porphy-
rin, carnosine, estrogens, coenzyme Q10, polyamines, saturated fatty acids, 
flavonoids which stabilize the cell membrane and are used in eye diseases, 
phenols, and polyphenols. Ceruloplasmin is an extracellular copper-transport 
protein.
3.1 Antioxidant enzymes
The most important antioxidant enzymes in newborns are: superoxide dis-
mutase, catalase, and glutathione peroxidase.
Superoxide dismutase has three forms: MnSOD located in mitochondria, 
copper-zinc superoxide dismutase (Cu/ZnSOD) in the cytoplasm, and extracellular 
superoxide dismutase (EC-SOD). In newborns, the last one is located intracellularly 
in the cytoplasm, unlike in adults, where it is located extracellularly, as indicated by 
its name [23, 27].
Superoxide dismutase has the role of converting the highly toxic superoxide 
radical to hydrogen peroxide and water. Catalase and glutathione peroxidase 
convert hydrogen peroxide to water.
In the absence of catalase, a cascade reaction is triggered with the formation of 
hydroxyl radicals, which requires the presence of iron metal ions (Fe2+) and copper 
Cu2+, known as the Haber-Weiss reaction:
 H2O2 + Fe
2+ → OH• + OH− + Fe3+ (1)
The hydroxyl radical resulting from this reaction will attack the structures of the 
cell, causing its destruction.
In the intrauterine period, there is an interaction between the fetus, placenta, 
and uterus, which requires a redox signal with a role in maintaining the balance of 
this interaction and allowing the development of antioxidant systems in the fetal 
period.
The decrease in lipid peroxidation in the placenta with the evolution of preg-
nancy is an indirect marker of the development of antioxidant mechanisms with the 
increase of gestational age [18].
Normal vascular development is conditioned by the activity of nitric oxide con-
trolled by nitric oxide synthase. Nitric oxide plays a role in regulating the activity of 
antioxidant enzymes.
The protective role of SOD was demonstrated in experimental groups of 
animals—rats—at the Physiology Department of the University of Medicine, 
Cluj-Napoca, Romania [16]. The authors studied lipid peroxides as oxidative stress 
parameters by measuring malondialdehyde (MDA) and ceruloplasmin using the 
Ravin test [16].
The animals exposed to hypobaric hypoxia had, immediately after SOD 
administration, significantly increased malondialdehyde (MDA) values, 
which were close to the values found in unprotected animals exposed to hypo-
baric hypoxia. At 24 hours after SOD administration, in animals exposed to 
hypoxia, the values of MDA as a marker of lipid peroxidation were significantly 
decreased, being lower than those of the control group. In the case of cerulo-
plasmin, values were significantly lower in protected compared to unprotected 
animals [16].
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The preterm neonate is born before the antioxidant systems capable of neutral-
izing ROS are formed. Birth itself is an oxidative stress-inducing factor, which 
will cause, in conjunction with other factors mentioned before such as hypoxia, 
hyperoxia, reperfusion, or inflammation, the rapid exhaustion of impaired defense 
mechanisms in the premature newborn. Transplacental nutrient supply has an 
important role in the formation of antioxidant defense mechanisms. However, 
this supply is limited in the case of preterm neonates. Chorioamnionitis present 
in a relatively great number of premature births is an induction factor for MnSOD 
mRNA in fetal membranes. Antenatal corticosteroids, in addition to their role in 
early lung, brain, and intestinal maturation, influence stimulation of the activity of 
antioxidant enzymes: SOD, catalase, and glutathione transferase [25, 29].
The endogenous surfactant has SOD and catalase in its composition. Their 
antioxidant role in the surfactant is to prevent surfactant lipid peroxidation and 
inactivation following the oxidative attack of ROS. These enzymes with antioxidant 
effects are not found in similar amounts in the exogenous surfactant used for the 
treatment of respiratory distress [30].
It is important to identify newborns at risk for oxidative stress in order to initiate 
early antioxidant therapy with a view to limiting oxidative stress progression. Since 
oxidative stress can frequently start during the intrauterine period, finding antioxi-
dant therapies for the mother with an impact on the newborn is essential.
3.2 Non-enzymatic antioxidants
Vitamins have an antioxidant role. Among water-soluble vitamins, vitamin C is 
the most studied. The most extensively studied lipid-soluble vitamins in neonates 
are vitamins A and E.
Vitamin A acts on retinol-binding proteins and on retinoic acid receptors. 
The main actions of retinol consist of maintaining epithelial integrity, regulating 
growth and proliferation, and modulating the levels of ceruloplasmin, a protein 
with antioxidant effects [2, 21]. Vitamin A levels are decreased in preterm new-
borns, proportionally to the degree of prematurity. The benefits of vitamin A in 
limiting the incidence of bronchopulmonary dysplasia have been described in 
many studies. Its beneficial effect in reducing the incidence of the disease could not 
be demonstrated. Also, the fact that it requires intramuscular administration and 
relatively high doses to exert its antioxidant effects is a major disadvantage [15, 22].
Regarding vitamins E and C, their beneficial effect in preventing the teratogenic 
effect of maternal diabetes has been studied by a number of authors [19].
In the category of water-soluble vitamins, other vitamins besides vitamin C have 
an antioxidant role: riboflavin, pyridoxine, and niacin, which maintain GSH activity.
Vitamin E is the antioxidant that is present in the highest amount in the human 
body. It is a lipophilic vitamin, which accumulates in lipid-rich cell membranes. It is 
an important lipid peroxyl scavenger [15].
Carotenoids are also lipid-soluble and have a characteristic color. Lutein plays 
a role in ROS elimination. In umbilical cord blood, studies have evidenced higher 
lutein levels in preterm compared to term newborns [29].
Ceruloplasmin is an extracellular antioxidant that acts like a ferroxidase enzyme, 
catalyzing the oxidation reaction of Fe2+ to Fe3+, thus limiting Haber-Weiss and 
Fenton reaction.
 LOH + Fe2+ → L▬O• +OH• + Fe3+ (2)
Uric acid is a non-enzymatic antioxidant resulting from purine metabolism. It 
is a scavenger of many ROS, but in certain situations, in excessive amounts, it has a 
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cytokine-mediated pro-inflammatory effect, playing a role in the pathogenesis of 
diseases such as diabetes [15, 30].
4. Evaluation of antioxidants in neonates
Antioxidant defense in neonates can be evaluated by measuring enzymatic and 
non-enzymatic systems. Among enzymatic systems, glutathione reductase, peroxi-
dase, transferase, the oxidized/reduced glutathione ratio, superoxide dismutase, 
as well as other antioxidants such as ceruloplasmin, transferring are the most 
frequently measured.
The non-enzymatic antioxidant systems that can be measured in newborns are 
vitamins A, E, and C. Vitamin A and E values measured in newborns are presented 
in many studies. Shah et al. describe a correlation between hepatic vitamin A 
reserves and gestational age, as well as between nutritional status and maternal 
vitamin A levels. Vitamin A has an important role in the development of visual 
acuity, and also in lung development and surfactant synthesis [1]. Vitamin A levels 
are significantly lower in preterm compared to term neonates. Antenatal corticoid 
administration has a beneficial effect on vitamin A levels in premature babies. Thus, 
in preterm newborns benefiting from antenatal corticosteroids, the levels of these 
vitamins with antioxidant effect are higher than in preterm babies without antena-
tal treatment. The mechanism of corticosteroids in increasing vitamin synthesis is 
unknown. It seems that these act by increasing the plasma levels of retinol-binding 
proteins, stimulating the hepatic synthesis of these proteins [2].
Vitamin E, another important non-enzymatic antioxidant, with a role in stabi-
lizing cell membranes, also has lower values in preterm compared to term neonates. 
Vitamin E has been used in many studies for its antioxidant effect in preventing 
retinopathy and bronchopulmonary dysplasia. However, in a 2003 Cochrane analy-
sis, Brion et al. demonstrated that vitamin E plays a role in reducing the incidence 
of ROP and IVH, but increases the incidence of neonatal sepsis [3]. Allopurinol, 
melatonin, and acetylcysteine have been used in studies for their antioxidant 
effect, mainly as neuroprotective agents. Melatonin and acetylcysteine were used 
in the studies of Gitto, and subsequently Barceló, to reduce the incidence of NEC in 
premature neonates [4, 5]. However, there is no consensus regarding their use for 
the treatment of NEC in neonates or for the treatment of other conditions associ-
ated with hypoxia-ischemia. Nevertheless, it should be taken into consideration that 
exogenous antioxidant therapy with high doses of vitamin C and beta-carotene in 
particular will have a pro-oxidant effect.
For the evaluation of antioxidant defense in newborns, the levels of ceruloplas-
min were measured in our service. This non-enzymatic antioxidant defense marker 
proved to be deficient in preterm compared to term neonates. Ceruloplasmin is a 
peroxyl radical scavenger. Free oxygen radical excess caused by certain oxidative 
stress-inducing situations will put a strain on the impaired defense mechanisms of 
the premature newborn. Antioxidant values will be lower compared to those of full-
term newborns. Ceruloplasmin determined by spectrophotometry had lower values 
in preterm neonates with respiratory distress. Also, ceruloplasmin levels decreased 
with the decrease in gestational age. Determinations evidenced lower ceruloplasmin 
values on the first day compared to the third day of life (Table 1).
Exposure to asphyxia at birth results in decreased ceruloplasmin levels. Under 
these oxidative stress-inducing conditions, the measurements performed evidenced 
lower ceruloplasmin values in preterm newborns with asphyxia compared to term 
newborns with asphyxia. Asphyxia is followed by a diminution of antioxidant levels 
and an increase in transferrin saturation. Current data confirm the fact that in 
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neonatal asphyxia and in the post-asphyxic period, ROS are generated particularly 
during the re-oxygenation phase after perinatal asphyxia [10]. The brain is the most 
susceptible to oxidative injury, for the following reasons:
• Neuronal membranes are rich in polyunsaturated fatty acids, an important 
source of free oxygen radicals.
• The activity of antioxidant enzymes (catalase and SOD) is significantly 
diminished in the brain.
• Some brain areas are rich in iron [10]. The increase in CP in mild and severe 
asphyxia cases can represent a form of adaptation of the organism to the action 
of oxidative stress [15].
Ceruloplasmin was measured by Lindeman [23], who evidenced the fact that 
in premature newborns, its levels are constantly low until the age of 3–6 weeks. 
Its deficiency in premature newborns increases the risk of oxidative stress under 
conditions of exposure to the oxidative attack of ROS.
Another marker of antioxidant defense is represented by hydrogen donors. Like 
total antioxidant activity, these assess several natural non-enzymatic antioxidants: 
cysteine, glutathione, ascorbic acid, tocopherol, polyphenols, aromatic amines, and 
sulfhydryl protein groups. In the case of measurements performed with 1,1-diphe-
nyl-picrylhydrazyl in neonates admitted to our service, we found a correlation of 
hydrogen donor values with the severity of respiratory distress. The presence of 
respiratory distress was a triggering factor for hydrogen donors, stimulating their 
antioxidant activity in a group of patients with impaired enzymatic antioxidant 
defense (Table 2).
Hydrogen donor levels in healthy, late preterm newborns are higher compared to 
those of preterm newborns with oxidative stress-inducing conditions such as respi-
ratory distress or asphyxia at birth. Non-enzymatic antioxidant defense assessed 
by hydrogen donor values improves with time; our determinations showed signifi-
cantly higher values on the third day compared to the first day (p < 0.05) (Table 3).
The enzymatic antioxidants studied in neonates are: catalase (CAT), superoxide 
dismutase (SOD), and glutathione peroxidase (GSH-Px). These are endogenous 
antioxidants and have the following antioxidant action mechanisms: superoxide 
dismutase catalyzes superoxide radical dismutation, resulting in hydrogen peroxide. 
N T Z p-Level
FiO2—DOL1 & FiO2—DOL3 59 52,5000 6,149,591 0.000000
pH—DOL1 & pH—DOL3 60 175,5000 4,346,968 0.000014
pCO2—DOL1 & pCO2—DOL3 60 412,5000 3,429,860 0.000604
pO2—DOL1 & pO2—DOL3 60 573,0000 2,014,110 0.043999
SaO2—DOL1 & SaO2—DOL3 60 208,5000 3,761,957 0.000169
CP—DOL1 & CP—DOL3 60 492,0000 2,814,343 0.004888
FiO2-oxygen concentration; pH-value.
pCO2-CO2 partial pressure; pO2-oxygen partial pressure.
SaO2-oxygen saturation; CP-ceruloplasmin.
p-test significance; Z = test parameter.
Table 1. 
Evolution of ceruloplasmin on 1st vs 3rd day of life (DOL).
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Glutathione peroxidase and catalase catalyze hydrogen peroxide reduction to water 
and oxygen. Thus, they exert a protective effect against oxidative injury (Figure 1).
The levels of these enzymes decrease with the decrease in gestational age. 
Another factor that influences enzymatic antioxidant mechanisms is neonatal devel-
opment. In neonates with intrauterine growth restriction, the antioxidant enzymes 
SOD, CAT, and GSH-Px have lower values than in term AGA neonates [12, 13].
In our study, for the assessment of enzymatic antioxidant defense capacity, 
erythrocyte SOD was measured using the Winterbourn method. Hemoglobin 
concentration was determined in K3 EDTA samples by the Drabkin method. 
1st day 3rd day Stat (p-value)
Mild Stat (p-value)*b 42.20 (39.80-45.30)
−3.11 (0.0019)
46.65 (41.53-52.05)
−2.09 (0.0369)
2.42 (0.0157)
Moderate Stat (p-value)*b 62.70 (59.40-64.20)
1.55 (0.1218)
61.50 (60.43-64.35)
1.68 (0.0926)
0.00 (0.9999)
Severe Stat (p-value)*b 48.30 (46.48-51.31)
−1.02 (0.3082)
49.60 (45.30-54.00)
−0.91 (0.3650)
0.0 (0.9999)
bmedian (Q1-Q3), Q = quartile, Wilcoxon Matched Test
*as compared to control
Table 2. 
Hydrogen donors by severity of respiratory distress and comparisons with the controls.
Group n Mean±Stdev Std. Error Mean t-value (p-value)
HD 1 Case 24 45.82 ± 10.36 2.12 −2.64 (0.0124)
Control 13 54.38 ± 7.33 2.03
HD 2 Case 24 49.03 ± 11.97 2.44 −1.47 (0.1514)
Control 13 54.38 ± 7.33 2.03
Table 3. 
Hydrogen donors (HD) by groups.
Figure 1. 
Enzymatic antioxidant mechanism.
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Determinations in the study group of preterm neonates compared to the values 
of the control group including full-term newborns evidenced a statistically sig-
nificant difference, SOD values being higher in term newborns compared to the 
group of premature babies [6]. The same results were obtained in the case of SOD 
measurement using Ransod kits (Cat. No. SD 125, Randox Labs, UK). SOD activity 
was expressed as the amount of proteins leading to inhibition of 90% formazan 
(505 nm) using xanthine oxidase to generate superoxide radicals [7].
Other studies, as well as our findings show the fact that antioxidant defense is 
impaired in neonates. This impairment increases with the decrease in gestational 
age, but is also influenced by the association of oxidative stress-inducing factors 
that put a strain on the defective defense mechanisms of the newborn.
5. Antioxidant treatment
5.1 Enzymatic therapies
Animal studies have demonstrated the beneficial effects of SOD on ROS. SOD 
administration as aerosols in animals improved alveolar development in the case of 
bronchopulmonary dysplasia induced by the common action of multiple factors: 
prematurity, hyperoxia, and mechanical ventilation.
Cysteine, which has glutathione stimulating effects, was studied in premature 
babies. Glutathione is an important antioxidant and a cofactor for GPx. However, 
studies failed to demonstrate its beneficial effect in reducing oxidative stress, 
since the harmful effects of ROS could not be prevented by cysteine administra-
tion. Glutathione levels were significantly higher after cysteine administration. 
Administration of recombinant CuZnSOD to preterm babies during the intubation 
period led to a decrease in the incidence of wheezing episodes, but did not reduce 
the incidence of BPD compared to preterm babies who received placebo during the 
same period [20]. The incidence of ROP in preterm babies receiving this treatment 
also decreased [11].
5.2 Non-enzymatic therapies
The beneficial effects of vitamin E have been studied by different authors. 
Randomized controlled trials could not demonstrate the effect of vitamin E in 
preventing BPD. There are studies that evidence the beneficial effects of vitamin 
E in reducing the incidence of cerebral hemorrhage, while increasing the risk of 
neonatal sepsis; consequently, the risk exceeds the benefits provided by the antioxi-
dant effect.
A Cochrane analysis of vitamin A describes its role in preventing BPD, but 
neurological and respiratory development at 18–22 months is not superior in babies 
receiving vitamin A [15, 21].
Regarding vitamin C, studies have demonstrated that in addition to its antioxi-
dant effect, in certain situations, after a significant oxidative attack, vitamin C can 
act as a pro-oxidant and will cause additional injuries [13, 15].
High vitamin C concentrations will inhibit ceruloplasmin and will induce oxida-
tion of Fe2+, which will have a catalytic action in lipid peroxidation and thus will 
generate new free radicals [23].
Excess of protein-unbound iron has a pro-oxidant effect, resulting in the pro-
duction of free radicals with harmful effects. Lactoferrin has a key role in limiting 
the pro-oxidant action of free iron, its presence in milk formulas being particularly 
important [22, 28].
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5.3 Other antioxidant therapies
Resveratrol is known for its antioxidant effect in astrocytes. Its role is important 
after asphyxia episodes. It acts by stimulating glutamate synthase activity and 
increases GSH levels in hippocampal astrocytes. The increase in glutamate synthase 
activity counters the toxic effect of glutamate.
Melatonin is a substance studied for its antioxidant effect. It has a role in repairing 
leukomalacia lesions, but its beneficial action has been described when it is admin-
istered early, in the first 2 hours after injury. Animal studies have demonstrated 
beneficial effects of enteral arginine and glutamine in preventing NEC [4, 5, 28].
Human milk feeding has a number of benefits over formulas. Studies demon-
strate the antioxidant effect of breast milk, which contributes to ROS elimination. 
Higher amounts of oxidative stress metabolites are eliminated in the urine of 
preterm babies fed with formula compared to those fed with breast milk. Oxidative 
stress is increased in premature neonates fed with formula. The antioxidant capac-
ity of breast milk is higher than that of neonatal blood [24].
Author details
Melinda Matyas* and Gabriela Zaharie
University of Medicine and Pharmacy, Cluj-Napoca, Romania
*Address all correspondence to: melimatyas@yahoo.com
10
Antioxidants
[1] Saugstad OD. Optimal oxygenation 
at birth and in the neonatal period. 
Neonatology. 2007;91:319-322
[2] Biesalski HK, Nohr I. Importance 
of vitamin-A for lung function and 
development. Molecular Aspects of 
Medicine. 2003;24:431-440
[3] Brion LP, Bell EF, Raghuveer TS.  
Vitamin E supplementation for 
prevention of morbidity and mortality 
in preterm infants. Cochrane 
Database of Systematic Reviews. 2003;4: 
CD003665
[4] Gitto E, Karbownik M, Reiter RJ, 
et al. Effects of melatonin treatment in 
septic newborns. Pediatric Research. 
2001;50(6):756-760
[5] Sánchez-Barceló EJ, Mediavilla MD, 
Tan DX, Reiter RJ. Clinical uses of 
melatonin: Evaluation of human 
trials. Current Medicinal Chemistry. 
2010;17(19):2070-2095
[6] Matyas M, Zaharie G, Craciun C, 
Blaga L. Evaluation of superoxide 
dismutase in preterm newborns. 
Obsterica Ginecologia. 2012;LX:267-271
[7] Matyas M, Craciun C, Popescu A, 
Popa M. The activity of erythrocytes 
superoxide dismutase in premature and 
mature infants-the relationship with 
gestational age. Physiology. 2007;17, 
1(53):25-28
[8] Gitto E, Reiter RJ, Xian-Tan D, 
Barberi I. Respiratory distress syndrome 
in the newborn: Role of oxidative 
stress. Intensive Care Medicine. 
2001;27:1116-1123
[9] Allen RG, Tresini M. Oxidative 
stress and gene regulation. Free Radical 
Biology & Medicine. 2000;28:463-499
[10] Sola A, Rodigo MR, Deulofeut R. 
Oxygen as a neonatal health hazard: 
Call for détente in clinical practice. Acta 
Paediatrica. 2007;96(6):801-812
[11] Ozsurekci Y, Aykac K. Oxidative 
stress related diseases in newborns. 
Oxidative Medicine and Cellular 
Longevity. 2016;15:1-9
[12] Gupta BP, Narang S, Banerjee BD.  
Oxidative stress in term small for 
gestational age neonates born to 
undernourished mothers: A case control 
study. BMC Pediatrics. 2004;4:14. DOI: 
10.1186/1471-2431-4-14
[13] Shoji H, Koletzko B. Oxidative 
stress and antioxidant protection in the 
perinatal period. Current Opinion in 
Clinical Nutrition and Metabolic Care. 
2007;10(3):324-328
[14] Martin A, Camille F, Debevec T, 
Rytz C, Millet G, Pialoux V. Preterm 
birth and oxidative stress: Effects of 
acute physical exercise and hypoxia 
physiological responses. Redox Biology. 
2018;17:315-322
[15] Buonocore G, Groenendaal F. Anti-
oxidant strategies. Seminars in Fetal & 
Neonatal Medicine. 2007;12:287e295
[16] Muresan A. Reactive Oxygen Species 
in Clinical Pathology. Romania: Editura 
Dacia; 1997:24-30. ISBN: 35-0703-2
[17] Matyas M, Zaharie G. Particularities 
of oxidative stress in newborns in Novel 
Propsects in Oxidative and Nitrosative 
Stress by Pinar Atukeren, IntechOpen: 
Rijeka 2018; 93-109
[18] Quango S, Mukherjea M. Ontogenic 
profile of some antioxidants and lipid 
peroxidation in human placental and 
fetal tissue. Molecular and Cellular 
Biochemistry. 2000;215(1-2):11-19
[19] Dheen ST, Tay SS, Boran J, et al. 
Recemnt studies on neural tube defects 
in embryos of diabetic pregnancy: An 
References
11
Antioxidants at Newborns
DOI: http://dx.doi.org/10.5772/intechopen.85175
overview. Current Medicinal Chemistry. 
2009;16:2345-2354
[20] Davis JM, Parad R, Michele T,  
Allred E, Price A, Rosenfeld W. 
Pulmonary outcome at 1 year corrected 
age in premature infants treated at birth 
with recombinant human CuZn SOD 
dismutase. Pediatrics. 2003;111:469-476
[21] Ambalavanan N, Tyson JE, 
Kennedy KA, et al. Vitamin A 
supplementation for extremely low 
birth weight infants: Outcome at 18-22 
months. Pediatrics. 2005;115:249-254
[22] Collard KJ. Iron homeostasis in the 
neonate. Pediatrics. 2009;123:1208-1216
[23] Lindeman JH, Lentjes EG, 
van Zoeren-Grobben D, Berger HM.  
Postnatal changes in plasma 
ceruloplasmin and transferrin 
antioxidant activities in preterm babies. 
Biology of the Neonate. 2000;78:73-76
[24] Ledo A, Arduini A, Asensi MA, 
et al. Human milk enhances antioxidant 
defenses against hydroxyl radical 
aggression in preterm infants. The 
American Journal of Clinical Nutrition. 
2009;89:210-215
[25] Sahni PV, Zhang J, Sosunov S, 
Galkin A, Niatsetskaya Z, Starkov A, 
et al. Krebs cycle metabolites and 
preferential succinate oxidation 
following neonatal hypoxic-ischemic 
brain injury in mice. Pediatric Research. 
2018;83:491-497
[26] Perlman JM, Wyllie J, Kattwinkel J, 
Wyckoff MH, Aziz K, Guinsburg R, 
et al. Part 7: Neonatal resuscitation: 
2015 International consensus on 
cardiopulmonary resuscitation and 
emergency cardiovascular care science 
with treatment recommendations. 
Pediatrics; 2015(Suppl 2):136, S120-S166
[27] Kuligowski J, Aguar M, Rook D, 
Lliso I, Torres-Cuevas I, Escobar J, et al. 
Urinary lipid peroxidation byproducts: 
Are they relevant for redicting 
neonatal morbidity in preterm infants? 
Antioxidants & Redox Signaling. 
2015;23:178-184
[28] Sánchez-Illana Á, Thayyil S, 
Montaldo P, Jenkins D, Quintás G, 
Oger C, et al. Novel free-radical 
mediated lipid peroxidation biomarkers 
in newborn plasma. Analytica Chimica 
Acta. 2017;996:88-97
[29] Picone S, Ritieni A, Fabiano A, 
Troise AD, Graziani G, Paolillo P, 
et al. Arterial cord blood lutein 
levels in preterm and term healthy 
newborns are sex and gestational age 
dependent. Clinical Biochemistry. 
2012;45:1558-1563. DOI: 10.1016/j.
clinbiochem.2012.07.109
[30] Davis JM, Auten RL. Maturation 
of the antioxidant system and effects 
on preterm birth. Seminars in Fetal & 
Neonatal Medicine. 2010;15:191-195
